COVID-19 Gene Connective tissue CAV3 Mouse Actionability Dystrophine Clinical trial Nuclear envelope CSF protein Cardiomyopathy A-type lamin AAV VECTOR Acetyltransferase Allele-specific silencing therapy Maladies rares Myotubes INPP5K Therapy Joint laxity Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Muscular dystrophy MD Muscular dystrophy Heart Muscle MRI Dilated cardiomyopathy Errance diagnostique Emery-Dreifuss muscular dystrophy Myogenesis AAV Diagnosis COL1A1 Exome C2C12 Rare neuromuscular diseases Laminopathy BiP Laminopathie RNA interference Biomarker COL6A1 Lamins Duchenne muscular dystrophy BVES Heart failure POPDC1 LMNA-related congenital muscular dystrophy Lamin A/C LMNA gene Lamin A/C CRISPR Regeneration Autophagosome maturation Ehlers‐Danlos Syndrome LMNA gene Biological sciences Laminopathies CMTX Hypermobile EDS Mutations Congenital muscular dystrophy Treatment delay Dynamin 2 Cancer biomarkers C elegans Maladies rares et orphelines Patient registry Titin Myopathies Muscle Emerin Muscle biopsy LMNA Actionable gene Base de données FAIR Myologie Allele‐specific silencing therapy Angiotensin-converting enzyme inhibitors GNE A-type lamins Neuromuscular diseases Gene therapy Next generation sequencing Becker muscular dystrophy Rare diseases LGMD Allele-specific silencing IPSC Adult SMA Calcium handling Alternative splicing Myopathy Angiotensin-converting enzyme inhibitor Dystrophie musculaire Lamin A/C nuclei Treatment Skeletal muscle Cancer Centronuclear myopathy COL6A3 Collagen VI-related myopathies NGS collagen type VI congenital muscular dystrophy CMD limb-girdle muscular dystrophy LGMD muscular MRI neuromuscular disorders Butyrylcholinesterase